Drug subsidy is a question of humanity
The medicine this patient needed cost around HK$20,000 a month and was not listed under the Drug Formulary for public hospitals, that is, it was not a standard drug subsidised by the government.
The government wants to be certain of the effectiveness of costly drugs before subsidising them. However, I think it should be more humanitarian in its approach, especially as the Alliance for Rare Diseases estimates that about 7,500 patients in the city have rare diseases.
The Hong Kong government has huge cash reserves, it can easily help the needy get better medical treatment. The Drug Formulary should be revised for maximum mitigation of the financial burden of patients.
The government could also cooperate with pharmaceutical firms to develop drugs at a lower cost, and put more resources into research for new and improved drugs.
Heidi Keung, Kowloon Tong